stockrowCorbus Pharmaceuticals Holdings, Inc. (CRBP) vs Cardiff Oncology, Inc. (CRDF)
- Corbus Pharmaceuticals Holdings, Inc. CRBP 2.86 −19.89%
- Cardiff Oncology, Inc. CRDF 0.76 −12.64%
Corbus Pharmaceuticals Holdings, Inc. and Cardiff Oncology, Inc. are both Biotechnology companies. Corbus Pharmaceuticals Holdings, Inc. and Cardiff Oncology, Inc. are of similar size ($58.8M and $55.3M). Cardiff Oncology, Inc. grew revenue faster over the last twelve months: −6.79% against −73.7%. Corbus Pharmaceuticals Holdings, Inc. has the higher net margin (0.00% vs −7,889.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Cardiff Oncology, Inc. leads on 9 and Corbus Pharmaceuticals Holdings, Inc. on 7.
Valuation
Profitability
| Metric | CRBP | CRDF | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (8,320.08%) | 0.00% |
| Net margin | 0.00% | (7,888.98%) | 0.00% |
| Free cash flow margin | 0.00% | (8,059.45%) | 0.00% |
| Return on equity | (95.58%) | (94.14%) | (50.12%) |
| Return on assets | (80.85%) | (70.89%) | (45.60%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack